Jump to top menu Jump to main menu Jump to content

Success stories

Licensing and spin-offs

Erasmus MC spin-off companies and their success stories showcase the change TTO brings about

Licensing

Discover the licensing landscape with the Technology Transfer Office (TTO) to bring your innovations to the market and patients 

At the Erasmus MC Technology Transfer Office, we foster innovation and facilitate the transfer of cutting-edge technologies from the researchers and clinicians to the marketplace. Our successful licensing agreements display our commitment to excellence and collaboration.

We have licensed out a diverse collection of groundbreaking inventions, each with the potential to make a significant impact. From life-saving drugs and advanced medical treatments to revolutionary medical devices that provide personalized solutions for patients , our portfolio showcases the breadth and depth of our research and clinical capabilities. In our licensing efforts we give importance to the 10 principles for socially responsible licensing, developed by the Netherlands Federation of University Medical Centers (NFU). These principles are designed to ensure that licensing agreements are not only commercially successful but also contribute to the welfare of society. Additionally, our advanced research materials, including cell lines, mouse models and questionnaires, care innovations developed by Erasmus MC’s Create4Care, and innovative software solutions are transforming industries and driving economic growth.

By partnering with industry leaders, we ensure that these pioneering technologies reach their full potential, benefiting society and driving progress. Our streamlined licensing process, tailored to meet the unique needs of each partner, has resulted in numerous success stories.

Join us in our mission to transform innovative ideas into impactful products and services. Together, we can shape patient care for the future.  

  • Story

    Success Story: LentiCure (Spin-off)

    LentiCure: Innovation in Gene Therapy for Rare Muscular Diseases. Erasmus MC spin-off company LentiCure develops an advanced and life-saving gene therapy for Pompe disease and bring it to the market at a socially responsible price

    Read more
  • Story

    Success Story: Ansh-labs

    Anti-Müllerian Hormone (AMH) assay.

    Read more
  • Story

    Success Story: Spatium Medical

    Spatium Medical is an innovative spin-off from Erasmus MC in Rotterdam, developing the next generation of insufflation technology.

    Read more

Testimonial

“My group has a very productive collaboration with TTO in order to valorize our research results. So far, his has resulted in multiple patents, a startup company for the development of gene therapy (LentiCure), and more to come in the near future.”

- Pim Pijnappel, professor cell –and gene therapy, Clinical Genetic

Success-stories